Total trials
81
Active
21
Phase 3
0
Total enrollment
46,729
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Metyrapone And Hydrocortisone | — | — | — | — | — | 1 | |
| Dextrose | — | — | — | — | — | 1 | |
| insulin | — | — | — | — | — | 1 | |
| Hemp-derived cannabinoids | — | — | — | — | — | 1 | |
| Zonisamide | — | — | — | — | — | 1 | |
| THC 20mg | — | — | — | — | — | 1 | |
| Mirtazapine | — | — | — | — | — | 1 | |
| Oxycodone | — | — | — | — | — | 1 | |
| Diclofenac | — | — | — | — | — | 1 | |
| Drug cocktail | — | — | — | — | — | 1 | |
| Cannabidiol in the form of hemp | — | — | — | — | — | 1 | |
| Clopidogrel | — | — | — | — | — | 1 |
Next readouts
- 2026-08-18
- 2026-11-01
- 2026-11-10
- 2026-12-01
- 2026-12-15
- 2027-08-31
- 2027-08-31
- 2028-05
- 2029-03
Top conditions
- Alcohol Use Disorder6
- Alcohol Use Disorder (AUD)4
- Interaction4
- Interaction Drug Food3
- Hypertension3
- Diabetes3
- Family Members3
- Opioid Use Disorder3
Frequently asked questions about Washington State University
- How many clinical trials does Washington State University have on ClinicalTrials.gov?
- Washington State University is listed as the lead sponsor on 81 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Washington State University's trials are in Phase 3?
- 0 of Washington State University's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does Washington State University focus on?
- Washington State University's most-studied conditions on ClinicalTrials.gov are Alcohol Use Disorder, Alcohol Use Disorder (AUD), Interaction, Interaction Drug Food, Hypertension.
- When are Washington State University's next clinical trial readouts?
- Washington State University has 9 upcoming primary-completion readouts tracked here; the soonest is “Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac”, expected around 2026-08-18.